Completed OBSERVATIONAL NCT04623281

Haemodialysis Outcomes & Patient Empowerment Study 02 (HOPE-02)

Sponsor: Beaumont Hospital

Conditions Dialysis; Complications End Stage Renal Disease Volume Overload

Updated 6 times since 2020 Last updated: Sep 2, 2021 Started: Jan 21, 2021 Primary completion: Jun 15, 2021 Completion: Jun 15, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04623281, this observational or N/A phase trial focuses on Dialysis; Complications and End Stage Renal Disease and remains completed. Sponsored by Beaumont Hospital, it has been updated 6 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Oct 2021 — Jul 2024 [monthly]

Completed

Status: Recruiting → Completed
Mar 2021 — Oct 2021 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting
Jan 2021 — Mar 2021 [monthly]

Not Yet Recruiting

▶ Show 1 earlier version

Dec 2020 — Jan 2021 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Beaumont Hospital
Design to Value Ltd
Enterprise Ireland
Royal College of Surgeons, Ireland
patientMpower Ltd.

Data source: Royal College of Surgeons, Ireland

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Dublin, Ireland